This increased expression of LAT1 in human tumors, along with its prominent presence in the BBB and distribution on both the luminal and abluminal sides of brain capillary endothelial and parenchymal cells [110], establishes LAT1 as a compelling therapeutic target for brain tumor treatment. Here, SLC7A5 is linked to brain neoplasm.